Chemotherapy Regimen for Pancreatic Cancer Receives Approval for First-line Therapy
The FDA has approved irinotecan liposome plus chemotherapy for the first-line treatment of metastatic pancreatic cancer. The U.S. Food and Drug Administration (FDA) has approved irinotecan liposome (Onivyde), in combination with the chemotherapeutics oxaliplatin,...